State NY
Clinical Trials in New York
Recruiting clinical trials with at least one study location in New York. Data updated daily from ClinicalTrials.gov.
Top Conditions in New York
NCT05643534 Phase 3
Recruiting
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pedia...
Condition
Irritable Bowel Syndrome With Constipation (IBS-C)
Enrollment
180 pts
Location
United States
Sponsor
Ardelyx
NCT06735534 N/A
Recruiting
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Cath...
Condition
Persistent Atrial Fibrillation
Enrollment
376 pts
Location
United States, Australia, Taiwan
Sponsor
Boston Scientific Corporation
NCT07159633 N/A
Recruiting
OurRelationship-S: A Digital Relationship-Strengthening Program for Couples Expe...
Condition
Relationship Conflict
Enrollment
120 pts
Location
United States
Sponsor
OurRelationship
NCT05714449 N/A
Recruiting
OCT Eccentric Fixation and Amblyopia in Children
Condition
Amblyopia
Enrollment
30 pts
Location
United States
Sponsor
State University of New York C
NCT06947993 Phase 2
Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s...
Condition
Atopic Dermatitis
Enrollment
224 pts
Location
United States, Argentina, Canada
Sponsor
Novartis Pharmaceuticals
NCT05850689 Phase 3
Recruiting
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Ma...
Condition
Major Depressive Disorder
Enrollment
470 pts
Location
United States, Bulgaria, France
Sponsor
Intra-Cellular Therapies, Inc.
NCT06481943 N/A
Recruiting
A Prospective Research Investigation of Ischemia Using MCG
Condition
Acute Coronary Syndrome
Enrollment
150 pts
Location
United States
Sponsor
SB Technology, Inc.
NCT06369623 N/A
Recruiting
Monetary Incentive Delay Task for Probing Reward-related Neural Processes
Condition
Adolescent Development
Enrollment
300 pts
Location
United States
Sponsor
Stony Brook University
NCT05285891 Phase 4
Recruiting
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
Condition
Multiple Sclerosis
Enrollment
123 pts
Location
United States
Sponsor
National Institute of Allergy
NCT06126276 Phase 2
Recruiting
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Tar...
Condition
Malignant Female Reproductive System Neoplasm
Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05878717 Phase 2, Phase 3
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosi...
Condition
Systemic Sclerosis Associated Interstitial Lung Disease
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT05919797 Phase 4
Recruiting
Weight Loss Study: Genetics and Response to Naltrexone/Bupropion
Condition
Obesity
Enrollment
120 pts
Location
United States
Sponsor
Columbia University
NCT04779918 N/A
Recruiting
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
Condition
Hernia, Ventral
Enrollment
160 pts
Location
United States
Sponsor
Tela Bio Inc
NCT05733013 N/A
Recruiting
A Study to Collect Information About the Use of Redifferentiating Medications as...
Condition
Thyroid Cancer
Enrollment
100 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06004440 N/A
Recruiting
Real World Registry for Use of the Ion Endoluminal System
Condition
Lung Cancer
Enrollment
3,000 pts
Location
United States
Sponsor
Intuitive Surgical
NCT06498960 N/A
Recruiting
Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in No...
Condition
Normal Pressure Hydrocephalus
Enrollment
230 pts
Location
United States, Argentina, Canada
Sponsor
CereVasc Inc
NCT05489588 N/A
Recruiting
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
Condition
Venous Thromboses
Enrollment
165 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT07422480 Phase 3
Recruiting
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With ...
Condition
Myelodysplastic Syndrome
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
NCT05234866 N/A
Recruiting
Paradoxical Lucidity in Severe End-Stage Dementia
Condition
Dementia
Enrollment
520 pts
Location
United States
Sponsor
NYU Langone Health
NCT06093672 Phase 3
Recruiting
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With P...
Condition
Polycythemia Vera
Enrollment
220 pts
Location
United States, Austria, Bulgaria
Sponsor
Italfarmaco
NCT05481879 Phase 1, Phase 2
Recruiting
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DY...
Condition
Myotonic Dystrophy Type 1 (DM1)
Enrollment
116 pts
Location
United States, Australia, France
Sponsor
Dyne Therapeutics
NCT05618353 Phase 4
Recruiting
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
Condition
Coronary Artery Disease
Enrollment
700 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT05769153 Phase 1, Phase 2
Recruiting
Study of AR-14034 in Participants With Neovascular Age-Related Macular Degenerat...
Condition
Neovascular Age-related Macular Degeneration (nAMD)
Enrollment
140 pts
Location
United States
Sponsor
Alcon Research
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06990529 Phase 2
Recruiting
Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation
Condition
PIDs Linked to PI3K
Enrollment
12 pts
Location
United States, Spain
Sponsor
Pharming Technologies B.V.